Selected article for: "early stage and growth model"

Author: Xiang Zhou; Na Hong; Yingying Ma; Jie He; Huizhen Jiang; Chun Liu; Guangliang Shan; Longxiang Su; Weiguo Zhu; Yun Long
Title: Forecasting the Worldwide Spread of COVID-19 based on Logistic Model and SEIR Model
  • Document date: 2020_3_30
  • ID: 52zjm9jt_50
    Snippet: The results of spreading potentials show that the R 0 of COVID-19 is high, which is similar to that of SARS viruses (R 0 values between 2.0 and 5.0 22 ), higher influenza viruses H1N1 (R 0 values between 1.2 and 3.7 23 ), and Ebola viruses (R 0 values between 1.34 and 3.65 24 ). COVID-19 is a highly contagious human-to-human transmission disease. The R 0 is expected to decrease substantially compared to values at the early stage after governments.....
    Document: The results of spreading potentials show that the R 0 of COVID-19 is high, which is similar to that of SARS viruses (R 0 values between 2.0 and 5.0 22 ), higher influenza viruses H1N1 (R 0 values between 1.2 and 3.7 23 ), and Ebola viruses (R 0 values between 1.34 and 3.65 24 ). COVID-19 is a highly contagious human-to-human transmission disease. The R 0 is expected to decrease substantially compared to values at the early stage after governments implement control measures; however, regardless of the kind of policy each country executes, each policy has its limitations in defending against COVID-19, and sustained transmission chains will occur until there is a vaccine or the until the virus disappears due to seasonal or population immunity 25 From the view of mathematical models, the SEIR model is designed for infectious disease estimation; however, the logistic growth model is designed to fit the development of the curves.

    Search related documents:
    Co phrase search for related documents
    • control measure and Ebola virus: 1
    • control measure and growth model: 1, 2, 3
    • control measure and human human: 1, 2, 3, 4, 5
    • control measure and human human transmission: 1, 2, 3, 4
    • curve development and growth model: 1
    • disease estimation and early stage: 1, 2, 3, 4, 5
    • disease estimation and Ebola virus: 1
    • disease estimation and human human: 1, 2
    • disease estimation and human human transmission: 1
    • early stage and Ebola virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • early stage and growth model: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • early stage and human human: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • early stage and human human transmission: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • early stage value and human human: 1
    • early stage value and human human transmission: 1
    • Ebola virus and growth model: 1, 2, 3, 4, 5, 6, 7
    • Ebola virus and human human: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • Ebola virus and human human transmission: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • growth model and human human transmission: 1, 2, 3, 4